Sir, Persister cells are bacterial cells that survive in high concentrations of antibiotics despite their antibiotic susceptibility, and have been discovered in many bacterial pathogens.
1 It has been suggested that persister cells might be one of the reasons for the failure of antibiotic treatment and might contribute to the evolution of antibiotic resistance. 2 Formation of persister cells against polymyxins (polymyxin B and colistin), which are regarded as last-resort antibiotics to treat MDR Gram-negative pathogens, has also been reported. 3 In this study, we studied variations in the rate of formation of persisters against colistin in Acinetobacter baumannii isolates causing bloodstream infections and its associations with genotype and clinical results.
We collected 45 strains of colistin-susceptible A. baumannii (colistin MICs, 1 or 2 mg/L by method of broth microdilution), which were isolated from patients with bloodstream infections in the Samsung Changwon Hospital (Changwon, South Korea). Colistin was administered to treat infections. These A. baumannii strains showed 10 different STs in MLST analysis according to the Oxford scheme (Figure 1a) . 4 The most prevalent ST was ST191 (n " 19), followed by ST208 (n " 9) and ST357 (n " 6). Most of them belonged to clonal complex 208 (CC208), except four strains of three STs (ST229, ST1252, and ST1430). CC208 corresponds to global clone 2 (GC2), the most prevalent carbapenem-resistant A. baumannii clone worldwide including South Korea.
5 ST229 also belongs to a recently identified epidemic clonal lineage.
6
A persister cell formation assay was performed as previously described, 7 with minor modifications. Cells were grown until the exponential phase (OD 600 "0.5) and then exposed to colistin (5% MIC) at 37 C. Two colonies from each sample were re-inoculated into fresh LB broth and in vitro antimicrobial susceptibility tests were performed to ensure that the MIC values had not changed. As a result, the survival rates of persister cells showed continuous variations among strains. The highest survival rate obtained was 5.75%10
#5

+5.26%10
#5 in SCH32, and 10 strains showed no persister cell formation at all ( Figure 1a ). Although ST368 and ST229 strains showed very low or no persister cell formation, no distinct relationship between STs and persister cell formation was detected. For example, the most prevalent STs, ST191 and ST208, showed very diverse persister cell formation rates.
We also compared the rates of formation of persister cells with 7 day treatment results (failed or successful). Mean bacterial survival rates were found to be higher in strains with that could not be treated (0.63%10 #5 versus 1.22%10
#5
), but the differences were not significant (P " 0.1097) (Figure 1b) . However, it is to be noted that 7 day treatment failure (defined as a patient's death or bacterial survival) was not observed in 8 out of the 10 strains that showed no persister cell formation (Figure 1a) .
Persisters have been reported in many bacterial pathogens, but few reports have been published regarding the formation of persister cells in A. baumannii.
2,8 To the best of our knowledge, persistence against colistin has not been reported at all. A recent study even suggested that colistin might kill Escherichia coli persisters and enhance the activity of fluoroquinolones.
9 However, the results of our study showed that persister cells against colistin are formed in A. baumannii isolates. So far, no definitive mechanisms of persistence against colistin in A. baumannii have been proposed. The persister cell formation may not be associated with genotypes or diseases caused by A. baumannii infection. No significant relationship between persister cell formation rates and 7 day treatment results was observed because many factors regarding the underlying disease, antibiotic protocol and treatment duration, and other host factors, affected the prognosis. Our study has a limitation in that we did not analyse factors other than persister cell formation. However, it is to be noted that most of the isolates that showed no persister formation were cleared with colistin treatment. The clinical impact of persister formation on the treatment against bacterial infection is still unclear; thus, further studies with more cases are required. 
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